The all Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the all Hub cannot guarantee the accuracy of translated content. The all and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The ALL Hub is an independent medical education platform, sponsored by Jazz Pharmaceuticals, Amgen, and Pfizer and supported through an educational grant from the Hippocrate Conference Institute, an association of the Servier Group. The funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View all content recommended for you
How do you treat older patients with newly diagnosed B-ALL?
José María Ribera
Anita Rijneveld
Mark Litzow
Elias JabbourDuring the ALL Hub Steering Committee meeting, Hervé Dombret chaired a discussion on “How to treat older patients with newly diagnosed B-ALL?” featuring Elias Jabbour, José María Ribera, Anita Rijneveld, and Mark Litzow.
The key discussion topics included:
- Current approaches for newly diagnosed older patients with B-ALL
- Ongoing and emerging trials involving frontline immunotherapies, including blinatumomab and inotuzumab ogamacin for older patients with B-ALL
- The role of allogeneic stem cell transplantation in older patients with B-ALL
- Global differences in treatment approaches
How do you treat older patients with newly diagnosed B-ALL?